학술논문

Creatinine Clearance (CrCl) as a Predictive Marker for the Risk of Toxicity From Molecularly Targeted Agents (MTA) in Phase I Trials
Document Type
Journal
Source
EUROPEAN JOURNAL OF CANCER; SEP 2011, 47 pS154-pS154, 1p. Supplement: 1
Subject
Language
English
ISSN
09598049